Mots-clés
 > MYOBASE > BIOLOGIE > biologie par discipline > biologie moléculaire > technique de biologie moléculaire > technique immunologique > immunochimie > immunohistochimie
immunohistochimieSynonyme(s)histo-immuno-chimie ;histoimmunochimie ;immmunocytochemistry ;immuno-histochimie ;immunohistochemical ;immunostaining immunohistochemistry |
Documents disponibles dans cette catégorie (1001)
| Mettre toutes les notices dans le panier | Faire une suggestion | Ajouter un critère de rechercheEtendre la recherche sur niveau(x) vers le bas
Genetic and clinical findings in a Chinese cohort of patients with collagen VI-related myopathies
Fan Y, Liu A, Wei C, et al.
Clinical genetics, 2018
CASQ1 mutations impair calsequestrin polymerization and cause tubular aggregate myopathy
Böhm J, Lornage X, Chevessier F, et al.
Acta neuropathologica, 2018, 135, 1, p 149
Mitochondrial content is preserved throughout disease progression in the mdx mouse model of Duchenne muscular dystrophy, regardless of taurine supplementation
Barker RG, Wyckelsma VL, Xu H, et al.
American journal of physiology. Cell physiology, 2018, 314, 4, p 483
The Use of Antisense Oligonucleotides for the Treatment of Duchenne Muscular Dystrophy
Relizani K, Goyenvalle A
Methods in molecular biology, 2018, 1687, p 171
Dysregulated autophagy in restrictive cardiomyopathy due to Pro209Leu mutation in BAG3
Schänzer A, Rupp S, Graf S, et al.
Molecular genetics and metabolism, 2018, 123, 3, p 388
A Neuron-Specific Gene Therapy Relieves Motor Deficits in Pompe Disease Mice
Lee NC, Hwu WL, Muramatsu SI, et al.
Molecular neurobiology, 2018, 55, 6, p 5299
Necrosis in anti-SRP+ and anti-HMGCR+ myopathies: Role of autoantibodies and complement
Allenbach Y, Arouche-Delaperche L, Preusse C, et al.
Neurology, 2018, 90, 6, p 507
Cost-Effectiveness Analysis of Diagnosis of Duchenne/Becker Muscular Dystrophy in Colombia
Atehortúa SC, Lugo LH, Ceballos M, et al.
Value in health regional issues, 2018, 17
Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated alpha-dystroglycan levels in patients homozygous for common FKRP mutation
Alhamidi M, Brox V, Stensland E, et al.
Neuromuscular disorders : NMD, 2017, 27, 7, p 619
Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies
Arouche-Delaperche L, Allenbach Y, Amelin D, et al.
Annals of neurology, 2017, 81, 4, p 538
RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Suarez-Calvet X, Gallardo E, Pinal-Fernández I, et al.
Arthritis research & therapy, 2017, 19, 1
MLPA identification of dystrophin mutations and in silico evaluation of the predicted protein in dystrophinopathy cases from India
Deepha S, Vengalil S, Preethish-Kumar V, et al.
BMC Medical Genetics, 2017, 18, 1
Update on new muscle glycogenosis
Laforêt P, Malfatti E, Vissing J
Current opinion in neurology, 2017, 30, 5, p 449
Muscle spindle alterations precede onset of sensorimotor deficits in Charcot-Marie-Tooth type 2E
Villalon E, Jones MR, Sibigtroth C, et al.
Genes, brain, and behavior, 2017, 16, 2, p 260
A recessive mutation in beta-IV-spectrin (SPTBN4) associates with congenital myopathy, neuropathy, and central deafness
Knierim E, Gill E, Seifert F, et al.
Human genetics, 2017, 136, 7, p 903
Evaluation of coexisting polymyositis in feline myasthenia gravis: A case series
Mayousse V, Jeandel A, Blanchard-Gutton N, et al.
Neuromuscular disorders : NMD, 2017, 27, 9, p 804
Elevated Expression of Moesin in Muscular Dystrophies
Pines M, Levi O, Genin O, et al.
The American journal of pathology, 2017, 187, 3, p 654
The pathogenesis of dermatomyositis
Thompson C, Piguet V, Choy E
The British journal of dermatology, 2017, 179, 6, p 1256
Phenotypic Variability of Dystrophinopathy Symptomatic Female Carriers
Cotta A, Paim JF, Carvalho E, et al.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2017, 44, 3, p 304
Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification
Wilson K, Faelan C, Patterson-Kane JC, et al.
Toxicologic pathology, 2017, 45, 7, p 961
